|
Q2 2022
Filed on Aug 03, 2022
|
3,459
|
$51.62 - $95.52
$179K - $330K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
4,663
|
$20.19 - $42.76
$94.1K - $199K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
55,434
|
$5.8 - $10.48
$322K - $581K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
55,008
|
$0.83 - $1.66
$45.7K - $91.3K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
1,000
|
$10.65 - $14.69
$10.7K - $14.7K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
4,055
|
$39.2 - $63.44
$159K - $257K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
65
|
$87.14 - $115.38
$5.66K - $7.5K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
3,027
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
35,385
|
$57.42 - $62.62
$2.03M - $2.22M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
55,233
|
$54.46 - $62.29
$3.01M - $3.44M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
58,783
|
$10.06 - $19.12
$591K - $1.12M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
8,658
|
$46.98 - $49.67
$407K - $430K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
2,125
|
$107.21 - $111.93
$228K - $238K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
8,500
|
$25.01 - $44.47
$213K - $378K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
77,011
|
$56.05 - $74.6
$4.32M - $5.75M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
10,957
|
$31.06 - $36.47
$340K - $400K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
7,727
|
$31.32 - $39.07
$242K - $302K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
4,898
|
$63.29 - $83.65
$310K - $410K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
11,690
|
$5.27 - $7.52
$61.6K - $87.9K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
10,000
|
$11.7 - $14.07
$117K - $141K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
6,073
|
$27.9 - $40.54
$169K - $246K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
4,518
|
$41.14 - $51.0
$186K - $230K
|
|
Saba Capital Income & Oprnt
|
Q2 2022
Filed on Aug 03, 2022
|
12,316
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
3,956
|
$61.53 - $78.48
$243K - $310K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
20,604
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
2,385
|
$62.03 - $84.42
$148K - $201K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
15,683
|
$27.9 - $46.82
$438K - $734K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
11,836
|
$2.85 - $7.77
$33.7K - $92K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
198,227
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
2,321
|
$86.4 - $112.29
$201K - $261K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
2,418
|
$68.08 - $84.61
$165K - $205K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
6,286
|
$23.01 - $38.89
$145K - $244K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
27,815
|
$7.65 - $9.81
$213K - $273K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
19,000
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
77,081
|
$12.8 - $19.45
$987K - $1.5M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
10,000
|
$13.94 - $19.31
$139K - $193K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
12,745
|
$27.62 - $40.7
$352K - $519K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
7,808
|
$24.79 - $30.66
$194K - $239K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
3,343
|
$56.9 - $67.36
$190K - $225K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
47,000
|
N/A
|
|
Neurocrine Biosciences Inc
|
Q2 2022
Filed on Aug 03, 2022
|
28,000
|
N/A
|
|
Peoples United Financial Inc
|
Q2 2022
Filed on Aug 03, 2022
|
36,334
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
10,765
|
$1.15 - $2.53
$12.4K - $27.2K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
12,523
|
$53.01 - $96.03
$664K - $1.2M
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
7,148
|
$22.98 - $34.75
$164K - $248K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
3,318
|
$55.2 - $67.83
$183K - $225K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
4,425
|
$32.61 - $66.58
$144K - $295K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
17,027
|
N/A
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
5,426
|
$30.33 - $42.22
$165K - $229K
|
|
|
Q2 2022
Filed on Aug 03, 2022
|
2,310
|
$87.2 - $114.05
$201K - $263K
|
|